RxDoctor Payments DataLook up a doctor →

Anuradha Kollipara, MD

Internal Medicine · Fort Wayne, INNPI 1871523787

Payments from drug & device makers

$30,198in general payments, 2019–2025

Across 1,524 payments — averaging $19.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$5K
  • AstraZeneca$4K
  • Novo Nordisk$2K
  • Bayer$2K
  • Amgen$2K
  • GSK$1K
  • plus $14K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)354$4,809
AstraZeneca(2 entities)94$3,510
Novo Nordisk136$2,331
Bayer121$1,949
Amgen(2 entities)80$1,783
GSK95$1,339
Lilly USA, LLC85$1,274
Boehringer Ingelheim52$1,082
Pfizer69$941
Novartis30$677
Astellas Pharma US Inc21$675
Axsome Therapeutics, Inc.16$629
Johnson & Johnson(2 entities)15$553
Phathom Pharmaceuticals, Inc.15$551
Teva Pharmaceuticals USA, Inc.14$504
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC21$500
Nestle Healthcare Nutrition Inc.14$445
Sanofi-aventis U.S. LLC9$412
Daiichi Sankyo Inc.5$397
Esperion Therapeutics, Inc.12$388
Otsuka America Pharmaceutical, Inc.17$380
Biohaven Pharmaceuticals, Inc.12$308
Amarin Pharma, Inc.19$265
E.r. Squibb & Sons, L.L.C.16$240
Avanir Pharmaceuticals, Inc.8$232
Alnylam Pharmaceuticals Inc.5$225
Paratek Pharmaceuticals, Inc.8$222
Sunovion Pharmaceuticals Inc.17$199
Eisai Inc.7$197
Vanda Pharmaceuticals Inc.9$182
Corcept Therapeutics5$175
Abbott10$173
Exact Sciences9$163
Xeris Pharmaceuticals, Inc.9$160
Radius Health, Inc.3$151
SK Life Science, Inc.2$145
Merck9$135
Ironshore Pharmaceuticals Inc.2$131
Takeda Pharmaceuticals U.S.A., Inc.9$130
Shield Therapeutics Inc3$112
UCB, Inc.7$110
Biohaven Pharmaceutical Holding Company Ltd.6$109
Kowa Pharmaceuticals America, Inc.7$100
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)6$99
Mylan Specialty L.p.5$88
Ironwood Pharmaceuticals, Inc6$80
Currax Pharmaceuticals LLC5$71
Lundbeck LLC3$67
Sumitomo Pharma America, Inc.3$61
Antares Pharma, Inc.3$58
Vertex1$53
Insulet Corporation2$47
Adlon Therapeutics L.p.3$43
Supernus Pharmaceuticals, Inc.2$42
Grifols USA, LLC2$42
Dexcom, Inc.1$38
Idorsia Pharmaceuticals US Inc2$31
VBI Vaccine (delaware) Inc.1$30
Boston Scientific1$27
Actelion Pharmaceuticals US, Inc.1$26

How this compares

$30,198 in reported general payments places this provider in the 95th percentile of 1,747 internal medicine providers in Indiana.

See all internal medicine providers in Indiana →

Medicare billing

Part B allowed, 2024
$145,954
Medicare patients
236
Services billed
2,288

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other internal medicine in Fort Wayne

See the full list for Indiana →

Where these figures come from

Is this you, or does something look wrong? →